ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Rheumatology

Top Rheumatology Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DANIEL JACKSON M.D.

Rheumatology

8,474

$837K

728
350 are 65+

14%
patients receiving schedule two controlled substances

34%
patients receiving schedule three controlled substances

5%
prescriptions for patients 65+ for potentially dangerous drugs

17%
prescriptions for brand name drugs

$99
Average prescription price

ROBERT SYLVESTER M.D.

Rheumatology

3,343

$281K

549
328 are 65+

5%
patients receiving schedule two controlled substances

35%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

23%
prescriptions for brand name drugs

$84
Average prescription price

LEE KENDALL MD

Rheumatology

3,034

$737K

339
261 are 65+

0%
patients receiving schedule two controlled substances

11%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

30%
prescriptions for brand name drugs

$243
Average prescription price

GEOFFREY GRATWICK MD

Rheumatology

2,720

$1M

444
331 are 65+

3%
patients receiving schedule two controlled substances

11%
patients receiving schedule three controlled substances

1%
prescriptions for patients 65+ for potentially dangerous drugs

28%
prescriptions for brand name drugs

$369
Average prescription price

SIDNEY BLOCK MD

Rheumatology

2,431

$505K

387
295 are 65+

4%
patients receiving schedule two controlled substances

7%
patients receiving schedule three controlled substances

3%
prescriptions for patients 65+ for potentially dangerous drugs

22%
prescriptions for brand name drugs

$208
Average prescription price

FADI AJINE MD

Rheumatology

1,363

$435K

298
187 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

25%
prescriptions for brand name drugs

$319
Average prescription price

DEIRDRE GRAMAS M.D.

Rheumatology

1,351

$395K

229
180 are 65+

0%
patients receiving schedule two controlled substances

10%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

25%
prescriptions for brand name drugs

$293
Average prescription price

STEPHANIE GARTNER-FANBURG MD

Rheumatology

1,283

$352K

199
137 are 65+

8%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

27%
prescriptions for brand name drugs

$274
Average prescription price

DONALD KRAUSE MD

Rheumatology

834

$210K

135
83 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

27%
prescriptions for brand name drugs

$251
Average prescription price

CRISOSTOMO BALIOG MD

Rheumatology

343

$58.2K

57
23 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

16%
prescriptions for brand name drugs

$170
Average prescription price

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank